SCHEMBL1739997

SCHEMBL1739997

C[CH]Sc1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
CYP2A6 P11509 1/20 0.42
MAPT P10636 3/20 0.41
RAB9A P51151 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
NPC1 O15118 2/20 0.41
HTT P42858 1/20 0.41
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
MAOA P21397 2/20 0.37
MAOB P27338 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HSD17B10 Q99714 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
MMP2 P08253 1/20 0.34
MMP8 P22894 1/20 0.34
MMP14 P50281 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1738285 0.76 ACHE (0.44) LMNACYP2A6MAPTRAB9ANPSR1
SCHEMBL3392085 0.74 LMNA (0.42) LMNACYP2A6MAPTRAB9ANPSR1
SCHEMBL1739587 0.74 ACHE (0.39) MAPTHTTMEN1KMT2AMAOA
SCHEMBL1739837 0.74 CYP2A6 (0.42) LMNACYP2A6MAPTRAB9ANPSR1
SCHEMBL1739829 0.73 MEN1 (0.38) LMNACYP2A6MAPTRAB9ANPSR1
SCHEMBL95991 0.72
SCHEMBL9695604 0.72 RHEB (0.41) LMNAMEN1KMT2AALDH1A1CYP2C9
SCHEMBL1738328 0.70 CA1 (0.52) LMNACYP2A6MAPTRAB9ANPSR1
SCHEMBL31464838 0.70 MAPT (0.42) LMNACYP2A6MAPTRAB9ANPSR1
SCHEMBL96393 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879567-A1 AMINO ACID DERIVATIVES Pfizer Limited (GB) 2008-01-23 EP claimed
US-20060247291-A1 Amino acid derivatives PFIZER, INC. 2006-11-02 US claimed
WO-2006114707-A1 AMINO ACID DERIVATIVES PFIZER LIMITED (GB) 2006-11-02 WO claimed
US-8669025-B2 Polymerizable composition, cured film, color filter, method of producing color filter and solid-state image sensor FUJIFILM CORPORATION (JP) 2014-03-11 US disclosed
EP-2390272-A1 Polymerizable composition, cured film, color filter, method of producing color filter and solid-state image sensor FUJIFILM Corporation (JP) 2011-11-30 EP disclosed
US-20110255570-A1 ADAPTIVE FREQUENCY HOPPING IN TIME-SLOTTED BASED WIRELESS NETWORK HITACHI, LTD. (JP) 2011-10-20 US disclosed
US-7612226-B2 Amino acid derivatives PFIZER INC. (US) 2009-11-03 US disclosed
EP-1879567-A1 AMINO ACID DERIVATIVES Pfizer Limited (GB) 2008-01-23 EP disclosed
US-20060247291-A1 Amino acid derivatives PFIZER, INC. 2006-11-02 US disclosed
WO-2006114707-A1 AMINO ACID DERIVATIVES PFIZER LIMITED (GB) 2006-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247291-A1 Amino acid derivatives OPRL1, BCAT2, BCAT1 LMNA 4367/4885CYP2A6 2245/4885MAPT 2377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.